AI-generated summary
The authors studied 30 adults with mild to moderate dry eye who received three 15-minute sessions of 633 nm red light therapy over about two weeks. They report significant improvements in several tear and symptom measures, including symptom scores, but no significant change in corneal staining or meibomian gland loss. The authors conclude the therapy may help dry eye management in the early phases of treatment.
- Participants
- 30
- Who or what was studied
- Adults with mild to moderate dry eye disease (mean age 31.1 years)
- Wavelengths
- 633 nm
- Limits stated in the abstract
- The abstract describes a small single-arm study with no control group and only early-phase follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 633 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Low-level laser therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.